- Home
- XLO
as 10-31-2025 10:01am EST
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 40.9M | IPO Year: | 2021 |
| Target Price: | $3.00 | AVG Volume (30 days): | 585.4K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.61 - $1.70 | Next Earning Date: | 11-07-2025 |
| Revenue: | $15,001,000 | Revenue Growth: | 536.45% |
| Revenue Growth (this year): | 519.7% | Revenue Growth (next year): | 44.57% |
Latest Xilio Therapeutics Inc. News
XLO Breaking Stock News: Dive into XLO Ticker-Specific Updates for Smart Investing
Yahoo Finance Video
5 days ago
AI will 'amplify, not replace' human performance: Workday CEO
Yahoo Finance
5 days ago
'Premature to signal the all-clear': Markets cheered the CPI print — but Main Street isn’t feeling the relief
Benzinga
5 days ago
Grant Cardone Lays Out Why His Bitcoin Real Estate Hybrid Model Will Crush REITs
CNW Group
5 days ago
Media Advisory - Monday, October 27, 2025
AFP
5 days ago
Israel insists it calls shots in Gaza despite truce
BeInCrypto
5 days ago
Bitcoin’s Path To $120,000 Could Be Delayed as Illiquid Supply Shrinks
TheStreet
5 days ago
Walmart’s award-winning $168 Viktor & Rolf perfume with 4,300+ perfect ratings is on sale for only $78
Motley Fool
5 days ago
Could Investing $10,000 in Rigetti Computing Make You a Millionaire?
Compare XLO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XLO Xilio Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.